GH (Guardant Health) Shares Buyback Ratio %: -1.60 (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GH Guardant Health Inc GH
65 GF Score
Price $179.46
GF Value $66.62
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Guardant Health Shares Buyback Ratio %?

Guardant Health GH -2.04% 65 Shares Buyback Ratio % is -1.60 as of Sep. 20, 2026. GuruFocus rates GH with a GF Score™ of 65/100 and a GF Value™ of $66.62 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Guardant Health's current shares buyback ratio was -1.60%.

Guardant Health Shares Buyback Ratio % Related Terms

Guardant Health Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Guardant Health's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health Shares Buyback Ratio % Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.55 -0.84 -18.53 -1.94 -5.36

Guardant Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.67 -0.42 -4.50 -0.67 -1.60
GH
65GF Score
Guardant Health Inc GH
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health Shares Buyback Ratio % Calculation

Guardant Health's Shares Buyback Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(123.994006 - 130.635301) / 123.994006
=-5.36%

Guardant Health's Shares Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2026 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Mar. 2026 )
=(131.514404 - 133.612678) / 131.514404
=-1.60%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -1.60 mean?
Guardant Health (GH) has a Shares Buyback Ratio % of -1.60 as of Sep. 20, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Guardant Health and its competitors.
Is Guardant Health's Shares Buyback Ratio % too high?
Guardant Health's current Shares Buyback Ratio % is -1.60. Overall, Guardant Health has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Shares Buyback Ratio % compare to MEDP and DGX?
Guardant Health's Shares Buyback Ratio % of -1.60 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Medical Diagnostics & Research company?
A good Shares Buyback Ratio % depends on the Medical Diagnostics & Research industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Guardant Health and its competitors. Guardant Health's current Shares Buyback Ratio % is -1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Based on GuruFocus' analysis, Guardant Health (GH) is currently considered Significantly Overvalued. The stock's GF Value™ is $66.62, compared to a current price of $179.46 — trading 169.4% above its estimated fair value. The current Shares Buyback Ratio % is -1.60. Guardant Health's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Guardant Health (GH), the current Shares Buyback Ratio % is -1.60 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of $179.46 is trading 169.4% above its estimated GF Value™ of $66.62. GuruFocus considers Guardant Health to be Significantly Overvalued.

Key valuation signals for GH:

  • Shares Buyback Ratio %: -1.60
  • GF Value™: $66.62 vs. price of $179.46 (169.4% above fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guardant Health Business Description

Other Exchanges 1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
65GF Score

Get the complete analysis for GH

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$179.46
Price
$66.62
GF Value